How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey

How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey Publisher

Guignant M^{1, 2} ; Tedbirt B^{1, 2} ; Murrell DF³ ; Amagai M^{4, 5} ; Aoki V⁶ ; Bauer J⁷ ; Ciancinni G⁸ ; Culton D⁹ ; Daneshpazhooh M¹⁰ ; De D¹¹ ; Fairley J^{12, 13} ; Hall R¹⁴ ; Kim SC¹⁵ ; Korman NJ¹⁶ Show All Authors

Guignant M^{1, 2}
Tedbirt B^{1, 2}
Murrell DF³
Amagai M^{4, 5}
Aoki V⁶
Bauer J⁷
Ciancinni G⁸
Culton D⁹
Daneshpazhooh M¹⁰
De D¹¹
Fairley J^{12, 13}
Hall R¹⁴
Kim SC¹⁵
Korman NJ¹⁶
Kowalewski C¹⁷
Mimouni D^{18, 19}
Patsatsi A²⁰
Hebert V^{1, 2}
Saleh MAM²¹
Schmidt E^{22, 23}
Sprecher E²⁴
Uzun S²⁵
Venning V²⁶
Werth VP²⁷
Zillikens D²²
Joly P^{1, 2}

Show Affiliations

1. Department of Dermatology, Rouen University Hospital, Rouen, France
2. INSERM Unit 2345, French Reference Center for Autoimmune Bullous Diseases, Normandie University, Rouen, France
3. Department of Dermatology, St George Hospital, University of New South Wales Sydney, Kensington, Australia
4. Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
5. Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
6. Department of Dermatology and Allergology, University of Sao Paulo, Sao Paulo, Brazil
7. Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria
8. Department of Dermatology, Ospedale Classificato Cristo RE, Rome, Italy
9. Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
10. Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
11. Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
12. Department of Dermatology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States
13. Department of Veterans Affairs Medical Center, U.S. Department of Veterans Affairs, Iowa City, IA, United States
14. Duke Dermatology, Duke University School of Medicine, Durham, NC, United States
15. Department of Dermatology, Gangnam Severance Hospital, Seoul, South Korea
16. Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States
17. Department of Dermatology and Immunodermatology, Medical University of Warsaw, Warsaw, Poland
18. Department of Dermatology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
19. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
20. Department of Dermatology, â€œPapageorgiouâ€� General Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
21. Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
22. Department of Dermatology, University of Lubeck, Lubeck, Germany
23. The Lubeck Institute of Experimental Dermatology (LIED), University of Lubeck, Lubeck, Germany
24. Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
25. Department of Dermatology and Venereology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
26. Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
27. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States

Source: JID Innovations Published:2022

Abstract

Many treatments are currently proposed for treating patients with bullous pemphigoid (BP). We assessed treatment modalities of BP depending on the different countries, BP extent, and patients’ comorbidities. We surveyed worldwide experts about how they treat patients with BP. A total of 61 experts from 27 countries completed the survey. Severe and moderate BP were treated with oral prednisone (61.4 and 53.7%, respectively) or superpotent topical corticosteroids (CSs) (38.6 and 46.3%, respectively). Conventional immunosuppressants were more frequently combined with oral prednisone (74.5%) than with superpotent topical CS (37.5%) in severe BP. Topical CSs were mainly used in Europe in mild (81.1%), moderate (55.3%), and severe (54.3%) BP. In the United States of America and Asia, systemic CSs were mainly proposed for treating severe (77.8 and 100%, respectively), moderate (70 and 77.8%, respectively), and also mild (47.1 and 33.3%, respectively) BP. Most experts reduced the initial dose of oral CS in patients with diabetes mellitus (48.1%) or cardiac insufficiency (40.2%) but rarely changed BP treatment in patients with neurological disorders or neoplasia. This survey showed major differences in the way patients with BP are treated between AmeriPac countries (United State of America, Latin America, and Australia) and Asia on the one hand and Europe and the Middle East on the other hand. © 2022 The Authors

Related Docs

1. Bullous Pemphigoid, Nature Reviews Disease Primers (2025)

2. Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2022)

3. Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran, Acta Medica Iranica (2018)

4. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study, SKINmed (2017)

5. A Comprehensive Insight Into the Anti-Inflammatory Properties of Dapsone, Naunyn-Schmiedeberg's Archives of Pharmacology (2022)

Experts (# of related papers)

View all Related Experts

Maryam Daneshpajooh (4)

Arghavan Azizpoor (1)

Style	Citing Format
MLA	Guignant M, et al.. "How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey." JID Innovations, vol. 2, no. 4, 2022, pp. -.
APA	Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, Ciancinni G, Culton D, Daneshpazhooh M, De D, Fairley J, Hall R, Kim SC, Korman NJ, Kowalewski C, Mimouni D, Patsatsi A, Hebert V, Saleh MAM, ... Joly P (2022). How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey. JID Innovations, 2(4), -.
Chicago	Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, Ciancinni G, et al.. "How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey." JID Innovations 2, no. 4 (2022): -.
Harvard	Guignant M et al. (2022) 'How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey', JID Innovations, 2(4), pp. -.
Vancouver	Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, et al.. How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey. JID Innovations. 2022;2(4):-.
BibTex	@article{ author = {Guignant M and Tedbirt B and Murrell DF and Amagai M and Aoki V and Bauer J and Ciancinni G and Culton D and Daneshpazhooh M and De D and Fairley J and Hall R and Kim SC and Korman NJ and Kowalewski C and Mimouni D and Patsatsi A and Hebert V and Saleh MAM and Schmidt E and Sprecher E and Uzun S and Venning V and Werth VP and Zillikens D and Joly P}, title = {How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey}, journal = {JID Innovations}, volume = {2}, number = {4}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Guignant M AU - Tedbirt B AU - Murrell DF AU - Amagai M AU - Aoki V AU - Bauer J AU - Ciancinni G AU - Culton D AU - Daneshpazhooh M AU - De D AU - Fairley J AU - Hall R AU - Kim SC AU - Korman NJ AU - Kowalewski C AU - Mimouni D AU - Patsatsi A AU - Hebert V AU - Saleh MAM AU - Schmidt E AU - Sprecher E AU - Uzun S AU - Venning V AU - Werth VP AU - Zillikens D AU - Joly P TI - How Do Experts Treat Patients With Bullous Pemphigoid Around the World? an International Survey JO - JID Innovations VL - 2 IS - 4 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract